JG

John G. Geisler

Founder & Chief Scientific Officer

Mitochon Pharmaceuticals

Mitochon Pharmaceuticals Pipeline

DrugIndicationPhase
MP-101Multiple Indications (Neurodegenerative)Preclinical
MP-201Multiple Indications (Neurodegenerative)Preclinical